172 related articles for article (PubMed ID: 19803785)
1. Metabolic acetate therapy for the treatment of traumatic brain injury.
Arun P; Ariyannur PS; Moffett JR; Xing G; Hamilton K; Grunberg NE; Ives JA; Namboodiri AM
J Neurotrauma; 2010 Jan; 27(1):293-8. PubMed ID: 19803785
[TBL] [Abstract][Full Text] [Related]
2. Metabolic acetate therapy improves phenotype in the tremor rat model of Canavan disease.
Arun P; Madhavarao CN; Moffett JR; Hamilton K; Grunberg NE; Ariyannur PS; Gahl WA; Anikster Y; Mog S; Hallows WC; Denu JM; Namboodiri AM
J Inherit Metab Dis; 2010 Jun; 33(3):195-210. PubMed ID: 20464498
[TBL] [Abstract][Full Text] [Related]
3. A safety trial of high dose glyceryl triacetate for Canavan disease.
Segel R; Anikster Y; Zevin S; Steinberg A; Gahl WA; Fisher D; Staretz-Chacham O; Zimran A; Altarescu G
Mol Genet Metab; 2011 Jul; 103(3):203-6. PubMed ID: 21474353
[TBL] [Abstract][Full Text] [Related]
4. Post-Injury Administration of Mitochondrial Uncouplers Increases Tissue Sparing and Improves Behavioral Outcome following Traumatic Brain Injury in Rodents.
Pandya JD; Pauly JR; Nukala VN; Sebastian AH; Day KM; Korde AS; Maragos WF; Hall ED; Sullivan PG
J Neurotrauma; 2007 May; 24(5):798-811. PubMed ID: 17518535
[TBL] [Abstract][Full Text] [Related]
5. The protective effect of cyclosporin A upon N-acetylaspartate and mitochondrial dysfunction following experimental diffuse traumatic brain injury.
Signoretti S; Marmarou A; Tavazzi B; Dunbar J; Amorini AM; Lazzarino G; Vagnozzi R
J Neurotrauma; 2004 Sep; 21(9):1154-67. PubMed ID: 15453986
[TBL] [Abstract][Full Text] [Related]
6. Brain energy depletion in a rodent model of diffuse traumatic brain injury is not prevented with administration of sodium lactate.
Prieto R; Tavazzi B; Taya K; Barrios L; Amorini AM; Di Pietro V; Pascual JM; Marmarou A; Marmarou CR
Brain Res; 2011 Aug; 1404():39-49. PubMed ID: 21723535
[TBL] [Abstract][Full Text] [Related]
7. Hypothesis of the postconcussive vulnerable brain: experimental evidence of its metabolic occurrence.
Vagnozzi R; Signoretti S; Tavazzi B; Cimatti M; Amorini AM; Donzelli S; Delfini R; Lazzarino G
Neurosurgery; 2005 Jul; 57(1):164-71; discussion 164-71. PubMed ID: 15987552
[TBL] [Abstract][Full Text] [Related]
8. Early and sustained alterations in cerebral metabolism after traumatic brain injury in immature rats.
Casey PA; McKenna MC; Fiskum G; Saraswati M; Robertson CL
J Neurotrauma; 2008 Jun; 25(6):603-14. PubMed ID: 18454682
[TBL] [Abstract][Full Text] [Related]
9. Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease.
Madhavarao CN; Arun P; Moffett JR; Szucs S; Surendran S; Matalon R; Garbern J; Hristova D; Johnson A; Jiang W; Namboodiri MA
Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5221-6. PubMed ID: 15784740
[TBL] [Abstract][Full Text] [Related]
10. Increasing acetyl-CoA metabolism attenuates injury and alters spinal cord lipid content in mice subjected to experimental autoimmune encephalomyelitis.
Chevalier AC; Rosenberger TA
J Neurochem; 2017 Jun; 141(5):721-737. PubMed ID: 28369944
[TBL] [Abstract][Full Text] [Related]
11. Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase.
Chakraborty G; Mekala P; Yahya D; Wu G; Ledeen RW
J Neurochem; 2001 Aug; 78(4):736-45. PubMed ID: 11520894
[TBL] [Abstract][Full Text] [Related]
12. Soluble amyloid precursor protein alpha reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats.
Thornton E; Vink R; Blumbergs PC; Van Den Heuvel C
Brain Res; 2006 Jun; 1094(1):38-46. PubMed ID: 16697978
[TBL] [Abstract][Full Text] [Related]
13. Ketogenic diet prevents alterations in brain metabolism in young but not adult rats after traumatic brain injury.
Deng-Bryant Y; Prins ML; Hovda DA; Harris NG
J Neurotrauma; 2011 Sep; 28(9):1813-25. PubMed ID: 21635175
[TBL] [Abstract][Full Text] [Related]
14. Temporal window of metabolic brain vulnerability to concussions: mitochondrial-related impairment--part I.
Vagnozzi R; Tavazzi B; Signoretti S; Amorini AM; Belli A; Cimatti M; Delfini R; Di Pietro V; Finocchiaro A; Lazzarino G
Neurosurgery; 2007 Aug; 61(2):379-88; discussion 388-9. PubMed ID: 17762751
[TBL] [Abstract][Full Text] [Related]
15. Progress toward acetate supplementation therapy for Canavan disease: glyceryl triacetate administration increases acetate, but not N-acetylaspartate, levels in brain.
Mathew R; Arun P; Madhavarao CN; Moffett JR; Namboodiri MA
J Pharmacol Exp Ther; 2005 Oct; 315(1):297-303. PubMed ID: 16002461
[TBL] [Abstract][Full Text] [Related]
16. N-acetylaspartate as an acetyl source in the nervous system.
Mehta V; Namboodiri MA
Brain Res Mol Brain Res; 1995 Jul; 31(1-2):151-7. PubMed ID: 7476023
[TBL] [Abstract][Full Text] [Related]
17. Temporal and regional changes after focal traumatic brain injury.
Lescot T; Fulla-Oller L; Po C; Chen XR; Puybasset L; Gillet B; Plotkine M; Meric P; Marchand-Leroux C
J Neurotrauma; 2010 Jan; 27(1):85-94. PubMed ID: 19705964
[TBL] [Abstract][Full Text] [Related]
18. The molecular mechanisms affecting N-acetylaspartate homeostasis following experimental graded traumatic brain injury.
Di Pietro V; Amorini AM; Tavazzi B; Vagnozzi R; Logan A; Lazzarino G; Signoretti S; Lazzarino G; Belli A
Mol Med; 2014 Mar; 20(1):147-57. PubMed ID: 24515258
[TBL] [Abstract][Full Text] [Related]
19. Cerebral oxidative stress and depression of energy metabolism correlate with severity of diffuse brain injury in rats.
Tavazzi B; Signoretti S; Lazzarino G; Amorini AM; Delfini R; Cimatti M; Marmarou A; Vagnozzi R
Neurosurgery; 2005 Mar; 56(3):582-9; discussion 582-9. PubMed ID: 15730584
[TBL] [Abstract][Full Text] [Related]
20. Decrease and recovery of N-acetylaspartate/creatine in rat brain remote from focal injury.
Gasparovic C; Arfai N; Smid N; Feeney DM
J Neurotrauma; 2001 Mar; 18(3):241-6. PubMed ID: 11284545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
